Myriam Salem is currently serving as national supervisor of the Clinical Trial Compliance Program at Health Canada. She previously coordinated the Good Pharmacovigilance Practices inspection Program at Health Canada, worked as a pharmacovigilance scientific manager and a senior scientific evaluator for several years. She was involved in the implementation of several policies leading to a strengthened post market oversight of opioid products in Canada. Prior to joining Health Canada, she held various positions in the pharmaceutical industry and academia. She is a biochemist by training and holds a master’s degree in pharmacology from Université de Montréal and a master’s degree in Pharmacovigilance and Pharmacoepidemiology. Myriam has been chairing the Pharmaceutical Inspection Co-operation Scheme (PIC/s) GVP Expert Circle - Artificial Intelligence and Machine Learning Working Group since 2023.